Stock listing
CALC Stock Price, News, Filings & Events — Calcimedica, Inc.
Selected listing: CALC · NASDAQ · USD · US
This page tracks Calcimedica, Inc.'s CALC:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CALC:NASDAQ. CALC:NASDAQ is the stock-level entry point for investors researching Calcimedica, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Calcimedica, Inc. is a public company traded under the ticker CALC in the American market. With a market capitalization of approximately $23.36 million, the company focuses on developing innovative solutions in its field. Investors can find detailed information about Calcimedica's operations and performance on its dedicated public company page.

- Ticker
- CALC:NASDAQ
- Asset type
- Stock
- Market cap
- $13.5M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Calcimedica, Inc. CALC:NASDAQ stock context
This page tracks Calcimedica, Inc.'s CALC:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CALC:NASDAQ. CALC:NASDAQ is the stock-level entry point for investors researching Calcimedica, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Calcimedica, Inc. is a public company traded under the ticker CALC in the American market. With a market capitalization of approximately $23.36 million, the company focuses on developing innovative solutions in its field. Investors can find detailed information about Calcimedica's operations and performance on its dedicated public company page.
Latest news from Calcimedica, Inc.
CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
September 8, 2026
CalciMedica Announces One-for-Five Reverse Stock Split
August 27, 2026
CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates
August 11, 2026
CalciMedica Announces FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis and Identifies Disease's First Potential Re...
July 29, 2026
CalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension Program
June 24, 2026
Research Calcimedica, Inc.
Calcimedica, Inc. investor report
Review AI stock analysis and investor report context for CALC:NASDAQ.
Calcimedica, Inc. company profile
View the public company page for Calcimedica, Inc. on 6ix.
Calcimedica, Inc. news
Read company news and market updates connected to Calcimedica, Inc..
Calcimedica, Inc. investor events
Find investor webinars, events, and replay context for Calcimedica, Inc..